The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Evidex Alerts After 3 Months: What We’ve Learned

Posted by Bob Kyle on April 7, 2017

It has now been one full quarter since we launched Evidex Alerts, the service which keeps our clients on top of the latest Drug Label Changes, Regulatory Alerts and Clinical Safety Data in real-time.   Evidex Alerts have been a smashing success and our clients have openly thanked us making this information easier to follow.  One client in particular was amazed at how well we untangle the mess that is a drug label and pull out the important pieces of information that they need to know, when they need to know it.

Read More

Topics: FAERS, Clinical Trials, Label Change, Clinical Evidence

Help! There are too many FDA Label Changes and Boxed Warnings and I Don’t Know Which Ones to Pay Attention To!

Posted by Jim Davis on October 10, 2014


There was an interesting article in the October 2014 issue of Pharmacy Practice News called A Life Preserver for the Flood of Boxed Warnings, which discussed research conducted by Christine M. Cheng, PharmD from First DataBank, Inc. (FDB) (JAMA Intern Med 2014 Aug 15), about the increase in FDA Boxed Warnings since 1996. She found that out of 522 novel therapeutics, about one third were affected by a boxed warning, with many of them being implemented after the drug reached market. The research noted that the median time from approval to first post-market boxed warning was 4.2 years.

Read More

Topics: RxSignal, Label Change

Subscribe to Email Updates